It’s a no brainer just to do a single European trial if the FDA asks for two. Management needs to communicate this better to the market, The FDA decision is a setback but at the moment it is being treated by investors as a success v failure decision.
- Forums
- ASX - By Stock
- Ann: Invex Granted Type C Meeting with FDA
It’s a no brainer just to do a single European trial if the FDA...
Featured News
Add IXC (ASX) to my watchlist
(20min delay)
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.960M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 11800 | 6.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 38000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 11800 | 0.065 |
1 | 42774 | 0.064 |
1 | 500000 | 0.040 |
2 | 93889 | 0.036 |
1 | 100001 | 0.035 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 38000 | 1 |
0.150 | 713 | 1 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
0.000 | 0 | 0 |
Last trade - 16.12pm 27/12/2024 (20 minute delay) ? |
Featured News
IXC (ASX) Chart |
Day chart unavailable